Clinical Trial Update: Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa [Phase 1]

View source ↗

Summary

A Phase 1 study assessed the pharmacokinetics and fed-versus-fasted bioequivalence of 300 mg droxidopa capsules in symptomatic neurogenic orthostatic hypotensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Neurogenic Orthostatic Hypotension

Drugs mentioned

• Droxidopa (Droxidopa)

Snippet

Sponsor: Chelsea Therapeutics | Conditions: Symptomatic Neurogenic Orthostatic Hypotension | Phase 1 | Status: COMPLETED